1.This Act may be cited as
the Prostate Cancer Detection Research
and Education Act
.
2.Plan to develop
and validate a test or tests for prostate cancer
(a)The Secretary of Health and Human Services (referred to
in this Act as the Secretary), acting through the Director of the
National Institutes of Health, shall establish an advisory council on prostate
cancer (referred to in this Act as the advisory council) to draft
a plan for the development and validation of an accurate test or tests, such as
biomarkers or imaging, to detect and diagnose prostate cancer.
(b)
(1)
(A)The advisory council shall be comprised of the following
experts:
(i)A
designee of the Centers for Disease Control and Prevention.
(ii)A
designee of the Centers for Medicare & Medicaid Services.
(iii)A
designee of the Office of the Director of the National Cancer Institute.
(iv)A
designee of the Director of the Department of Defense Congressionally Directed
Medical Research Program.
(v)A
designee of the Director of the National Institute of Biomedical Imaging and
Bioengineering.
(vi)A
designee of the Director of the National Institute of General Medical
Sciences.
(vii)A
designee of the Director of the National Institute on Minority Health and
Health Disparities.
(viii)A designee of
the Office of the Director of the National Institutes of Health.
(ix)A
designee of the Food and Drug Administration.
(x)A
designee of the Agency for Healthcare Research and Quality.
(xi)A
designee of the Director of the Telemedicine and Advanced Technology Research
Center of the Department of Defense.
(B)In addition to the members described in subparagraph (A),
the advisory council shall include 8 expert members from outside the Federal
Government to be appointed by the Secretary, which shall include—
(i)2
prostate cancer patient advocates;
(ii)2
health care providers with a range of expertise and experience in prostate
cancer; and
(iii)4
leading researchers with prostate cancer-related expertise in a range of
clinical disciplines.
(2)The
advisory council shall meet quarterly and such meetings shall be open to the
public.
(3)The
advisory council shall advise the Secretary, or the Secretary’s
designee.
(4)Not later than 1 year after the date of enactment of this
Act, the advisory council shall provide to the Secretary, or the Secretary’s
designee and Congress—
(A)an initial
evaluation of all Federally funded efforts in prostate cancer research relating
to the development and validation of an accurate test or tests to detect and
diagnose prostate cancer;
(B)a plan for the
development and validation of a reliable test or tests for the detection and
accurate diagnosis of prostate cancer; and
(C)a set of
standards for prostate cancer screening, developed in coordination with the
United States Preventive Services Task Force, to ensure that any tools for
screening, detection, and diagnosis developed in accordance with the plan under
subparagraph (B) will meet the requirements of the Task Force for
recommendation as a proven preventive or diagnostic service.
(5)The
advisory council shall terminate on December 31, 2016.
(c)The
Secretary may make available $1,000,000 from amounts appropriated to the
National Institutes of Health for each of fiscal years 2013 through 2017 to
carry out this section.
3.Coordination and
intensification of prostate cancer research
(a)The Director of the National Institutes of Health, in
consultation with the Secretary of Defense, shall coordinate and intensify
research in accordance with the plan developed under section 2(b)(4)(B), with
particular attention provided to leveraging existing research to develop and
validate a test or tests, such as biomarkers or imaging, to detect and
accurately diagnose prostate cancer in order to improve quality of life for
millions of Americans, and decrease health care system costs.
(b)The
Secretary may make available $30,000,000 from amounts appropriated to the
National Institutes of Health for each of fiscal years 2014 through 2018 to
carry out this section.
4.Public awareness
and education campaign
(a)The Secretary, in coordination with the Director of the
National Institutes of Health and the Director of the Centers for Disease
Control and Prevention, shall carry out a national campaign to increase the
awareness and knowledge of prostate cancer.
(b)The
national campaign conducted under subsection (a) shall include—
(1)roles for the
National Cancer Institute, the National Institute on Minority Health and Health
Disparities, the Office on Minority Health of the Department of Health and
Human Services, and the Office of Minority Health of the Centers for Disease
Control and Prevention; and
(2)the development
and distribution of written educational materials, and the development and
placing of public service announcements, that are intended to encourage men to
seek prostate cancer screening when symptoms are present, when they have a
family history of prostate cancer, or if they belong to a high-risk
population.
(c)In developing the national campaign under subsection
(a), the Secretary shall recognize and address—
(1)the racial
disparities in the incidences of prostate cancer and mortality rates with
respect to such disease; and
(2)any barriers in
access to patient care and participation in clinical trials that are specific
to racial minorities.
(d)The
Secretary shall establish a program to award grants to nonprofit private
entities to enable such entities to test alternative outreach and education
strategies to increase the awareness and knowledge of Americans with respect to
prostate cancer.
(e)Authorization
of appropriationsThere is authorized to be appropriated to carry
out this section, $5,000,000 for each of fiscal years 2013 through 2017.